Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and survival of nivolumab treatment for recurrent/unresectable esophageal squamous-cell carcinoma: real-world clinical data from a large multi-institutional cohort.
Makino T, Nakai S, Momose K, Yamashita K, Tanaka K, Miyata H, Yamamoto S, Motoori M, Kimura Y, Ushimaru Y, Hirao M, Matsuyama J, Akamaru Y, Kurokawa Y, Eguchi H, Doki Y. Makino T, et al. Among authors: matsuyama j. Esophagus. 2024 May 8. doi: 10.1007/s10388-024-01056-w. Online ahead of print. Esophagus. 2024. PMID: 38717686
Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08).
Sunakawa Y, Sakamoto Y, Kawabata R, Ishiguro A, Akamaru Y, Kito Y, Takahashi M, Matsuyama J, Yabusaki H, Makiyama A, Suzuki T, Tsuda M, Yasui H, Hihara J, Takeno A, Inoue E, Ichikawa W, Fujii M. Sunakawa Y, et al. Among authors: matsuyama j. Oncologist. 2024 Apr 6:oyae056. doi: 10.1093/oncolo/oyae056. Online ahead of print. Oncologist. 2024. PMID: 38581687 Free article.
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study.
Saito T, Kurokawa Y, Fujitani K, Kawabata R, Takeno A, Mikami J, Endo S, Matsuyama J, Akamaru Y, Hirota M, Kishi K, Urakawa S, Yamamoto K, Tanaka K, Takahashi T, Oka M, Wada H, Eguchi H, Doki Y. Saito T, et al. Among authors: matsuyama j. Br J Cancer. 2024 Apr;130(7):1157-1165. doi: 10.1038/s41416-023-02540-3. Epub 2024 Feb 7. Br J Cancer. 2024. PMID: 38326601 Free PMC article.
Effects of postoperative oral elemental nutritional supplement on skeletal muscle loss after gastrectomy for gastric cancer.
Nishikawa K, Kimura Y, Kishi K, Inoue K, Matsuyama J, Akamaru Y, Tamura S, Kawada J, Kawase T, Kawabata R, Fujiwara Y, Kanno H, Yamada T, Shimokawa T, Imamura H. Nishikawa K, et al. Among authors: matsuyama j. Int J Clin Oncol. 2024 Mar;29(3):266-275. doi: 10.1007/s10147-023-02462-3. Epub 2024 Jan 16. Int J Clin Oncol. 2024. PMID: 38227091
Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902).
Kawase T, Imamura H, Kawabata R, Matsuyama J, Nishikawa K, Yanagihara K, Yamamoto K, Hoki N, Kawada J, Kawakami H, Sakai D, Kurokawa Y, Shimokawa T, Satoh T. Kawase T, et al. Among authors: matsuyama j. Int J Clin Oncol. 2024 Feb;29(2):134-141. doi: 10.1007/s10147-023-02437-4. Epub 2024 Jan 16. Int J Clin Oncol. 2024. PMID: 38227090 Clinical Trial.
188 results